These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Patients with chronic lymphocytic leukemia with mutated VH genes presenting with Binet stage B or C form a subgroup with a poor outcome. Tobin G; Thunberg U; Laurell A; Karlsson K; Aleskog A; Willander K; Söderberg O; Merup M; Vilpo J; Hultdin M; Sundström C; Roos G; Rosenquist R Haematologica; 2005 Apr; 90(4):465-9. PubMed ID: 15820941 [TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of ZAP-70 expression and Ig VH mutational status in B-cell chronic lymphocytic leukemia. Muñoz L; Lasa A; Carricondo MT; Hernández C; Ubeda J; Nomdedéu JF Cytometry B Clin Cytom; 2007 Mar; 72(2):96-102. PubMed ID: 17051526 [TBL] [Abstract][Full Text] [Related]
5. IgVH mutational status and clonality analysis of Richter's transformation: diffuse large B-cell lymphoma and Hodgkin lymphoma in association with B-cell chronic lymphocytic leukemia (B-CLL) represent 2 different pathways of disease evolution. Mao Z; Quintanilla-Martinez L; Raffeld M; Richter M; Krugmann J; Burek C; Hartmann E; Rudiger T; Jaffe ES; Müller-Hermelink HK; Ott G; Fend F; Rosenwald A Am J Surg Pathol; 2007 Oct; 31(10):1605-14. PubMed ID: 17895764 [TBL] [Abstract][Full Text] [Related]
7. Analysis of IgV gene mutations in B cell chronic lymphocytic leukaemia according to antigen-driven selection identifies subgroups with different prognosis and usage of the canonical somatic hypermutation machinery. Degan M; Bomben R; Bo MD; Zucchetto A; Nanni P; Rupolo M; Steffan A; Attadia V; Ballerini PF; Damiani D; Pucillo C; Poeta GD; Colombatti A; Gattei V Br J Haematol; 2004 Jul; 126(1):29-42. PubMed ID: 15198729 [TBL] [Abstract][Full Text] [Related]
8. VH gene mutation status and cellular drug resistance in chronic lymphocytic leukaemia. Aleskog A; Tobin G; Laurell A; Thunberg U; Lindhagen E; Roos G; Nilsson K; Nygren P; Sundström C; Höglund M; Larsson R; Rosenquist R Eur J Haematol; 2004 Dec; 73(6):407-11. PubMed ID: 15522062 [TBL] [Abstract][Full Text] [Related]
9. [A comparison of the forms of chronic lympholeukemia in relation to the mutational status of the genes of the immunoglobulin variable region]. Nikitin EA; Pivnik AV; Sudarikov AB; Valova GM; Gabeeva NG; Samoĭlova RS; Ivanov DV; Melikian AL; Kovaleva LG Ter Arkh; 2000; 72(7):52-6. PubMed ID: 10983322 [TBL] [Abstract][Full Text] [Related]
10. Hodgkin's disease variant of Richter's syndrome clonally related to chronic lymphocytic leukemia arises in ZAP-70 negative mutated CLL. Tzankov A; Fong D Med Hypotheses; 2006; 66(3):577-9. PubMed ID: 16223567 [TBL] [Abstract][Full Text] [Related]
11. V(H) gene usage differs in germline and mutated B-cell chronic lymphocytic leukemia. Duke VM; Gandini D; Sherrington PD; Lin K; Heelan B; Amlot P; Mehta AB; Hoffbrand AV; Foroni L Haematologica; 2003 Nov; 88(11):1259-71. PubMed ID: 14607755 [TBL] [Abstract][Full Text] [Related]
12. Structural and functional features of the B-cell receptor in IgG-positive chronic lymphocytic leukemia. Potter KN; Mockridge CI; Neville L; Wheatley I; Schenk M; Orchard J; Duncombe AS; Packham G; Stevenson FK Clin Cancer Res; 2006 Mar; 12(6):1672-9. PubMed ID: 16551848 [TBL] [Abstract][Full Text] [Related]
13. The origin of B-cell chronic lymphocytic leukemia. Ghia P; Caligaris-Cappio F Semin Oncol; 2006 Apr; 33(2):150-6. PubMed ID: 16616061 [TBL] [Abstract][Full Text] [Related]
14. What is the current evidence for antigen involvement in the development of chronic lymphocytic leukemia? Tobin G; Rosén A; Rosenquist R Hematol Oncol; 2006 Mar; 24(1):7-13. PubMed ID: 16315334 [TBL] [Abstract][Full Text] [Related]
16. Determination of how many immunoglobulin variable region heavy chain mutations are allowable in unmutated chronic lymphocytic leukaemia - long-term follow up of patients with different percentages of mutations. Hamblin TJ; Davis ZA; Oscier DG Br J Haematol; 2008 Feb; 140(3):320-3. PubMed ID: 18053068 [TBL] [Abstract][Full Text] [Related]
17. Select high-risk genetic features predict earlier progression following chemoimmunotherapy with fludarabine and rituximab in chronic lymphocytic leukemia: justification for risk-adapted therapy. Byrd JC; Gribben JG; Peterson BL; Grever MR; Lozanski G; Lucas DM; Lampson B; Larson RA; Caligiuri MA; Heerema NA J Clin Oncol; 2006 Jan; 24(3):437-43. PubMed ID: 16344317 [TBL] [Abstract][Full Text] [Related]
18. [Molecular genetic characterization of chronic lymphocytic leukemia aggressivity in Czech patients: a nucleotide variability of genes coding for heavy chain of immunoglobulin]. Kuhrová V; Francová H; Klimesová D; Brychtová Y; Doubek M; Trbusek M; Brejcha M; Dvoráková D; Mayer J Cas Lek Cesk; 2006; 145(11):855-8; discussion 859-60. PubMed ID: 17168419 [TBL] [Abstract][Full Text] [Related]
19. Allogeneic transplant with reduced intensity conditioning regimens may overcome the poor prognosis of B-cell chronic lymphocytic leukemia with unmutated immunoglobulin variable heavy-chain gene and chromosomal abnormalities (11q- and 17p-). Caballero D; García-Marco JA; Martino R; Mateos V; Ribera JM; Sarrá J; León A; Sanz G; de la Serna J; Cabrera R; González M; Sierra J; San Miguel J Clin Cancer Res; 2005 Nov; 11(21):7757-63. PubMed ID: 16278397 [TBL] [Abstract][Full Text] [Related]
20. Prognostic relevance of the FAB morphological criteria in chronic lymphocytic leukemia: correlations with IgVH gene mutational status and other prognostic markers. Schwarz J; Mikulenková D; Cermáková M; Polanská V; Michalová K; Marinov I; Campr V; Ransdorfová S; Marková J; Pavlistová L; Brezinová J; Sajdová J; Sponerová D; Volková Z; Benesová K; Cermák J; Vítek A; Cetkovský P Neoplasma; 2006; 53(3):219-25. PubMed ID: 16652191 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]